Showing results (71-80 of 89) with videos related to
Sort By:
Pageof 9
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 13, 2020
Integrative Analysis of Multi-omics Data Identified EGFR and PTGS2 as Key Nodes in a Gene Regulatory Network Related to Immune Phenotypes in Head and Neck CancerBohai Feng, Ying Shen, Xavier Pastor Hostench, et al.International Journal of Molecular Sciences|December 9, 2023
HLA-E and Its Soluble Form as Indicators of a Sex-Specific Immune Response in Patients with Oral Squamous Cell CarcinomaAnne Radermacher, Michael Fehrenz, Tamara Bellin, et al.Cancers|December 7, 2018
Intensity Modulated Radiotherapy (IMRT) + Carbon Ion Boost for Adenoid Cystic Carcinoma of the Minor Salivary Glands in the Oral CavityKristin Lang, Melissa Baur, Sati Akbaba, et al.Head & Neck|November 21, 2018
Cortactin expression: Association with disease progression and survival in oral squamous cell carcinomaDominik Horn, Madeleine Gross, Gerhard Dyckhoff, et al.International Journal of Cancer|November 13, 2014
Phosphorylation of AKT(Ser473) serves as an independent prognostic marker for radiosensitivity in advanced head and neck squamous cell carcinomaChristian Freudlsperger, Dominik Horn, Sebastian Weißfuß, et al.Oral Oncology|April 24, 2013
Lack of evidence of human papillomavirus-induced squamous cell carcinomas of the oral cavity in southern GermanyMiriam Reuschenbach, Katinka Kansy, Kira Garbe, et al.Frontiers in Oncology|August 16, 2021
Digital Pathology Scoring of Immunohistochemical Staining Reliably Identifies Prognostic Markers and Anatomical Associations in a Large Cohort of Oral CancersJulius Moratin, Andreas Mock, Sonja Obradovic, et al.International Journal of Cancer|September 15, 2020
Unraveling most abundant mutational signatures in head and neck cancerMichaela Plath, Johanna Gass, Mario Hlevnjak, et al.International Journal of Cancer|August 9, 2014
p16(INK4a) /Ki-67 co-expression specifically identifies transformed cells in the head and neck regionElena-Sophie Prigge, Csaba Toth, Gerhard Dyckhoff, et al.International Journal of Radiation Oncology, Biology, Physics|October 7, 2019
The Phase 1/2 ACCEPT Trial: Concurrent Cetuximab and Intensity Modulated Radiation Therapy with Carbon Ion Boost for Adenoid Cystic Carcinoma of the Head and NeckSebastian Adeberg, Sati Akbaba, Kristin Lang, et al.Pageof 9